Objective:

To address the rising incidence of prostate cancer in Asia and identify barriers to early detection and treatment.

Approach:

• Cultural Challenges: Discusses the taboo surrounding health issues related to the reproductive system, leading to delays in diagnosis.
• Misinformation: Highlights beliefs that prostate cancer only affects the elderly and that religious practices can replace medical care.
• Access to Screening: Notes the lack of systematic screening programs and uneven healthcare infrastructure across Asian countries.
• Emerging Diagnostic Technologies: Introduces the EpiSwitch test, a blood-based assay that detects prostate cancer with greater accuracy than traditional PSA tests.
• Recommendations: Calls for awareness campaigns, culturally sensitive outreach, and investment in diagnostics to improve early detection.

Key Findings:

• Prostate cancer is underreported in many Asian countries despite rising rates.
• Cultural stigma and access barriers contribute to underdiagnosis and delayed treatment.
• New diagnostic technologies like the EpiSwitch test may improve early detection.

Interpretation:

Limitations:

• Cultural taboos may hinder discussions about prostate health.
• Misinformation about prostate cancer prevalence affects public awareness.

Conclusion:

Sources:

• Cancers Review